Sunday, October 7, 2012

• VIVUS Announces Suit Dismissal and 4 Healthcare Stocks in Demandat Wall St. Cheat Sheet (Sun, Oct 7)

Saturday, October 6, 2012

• Did This High Dividend Stock Just Lower the Bar?at Motley Fool (Sat, Oct 6)

Friday, October 5, 2012

• 2-Star Stocks Poised to Plunge: Dendreon?at Motley Fool (Fri, Oct 5)

Thursday, October 4, 2012

• 3 Biotech Stocks That Will Be Making Big Movesat Motley Fool (Thu, Oct 4)

Wednesday, October 3, 2012

• Healthcare Business Review: Celgene Trial Meets Endpoints, Rosetta’s Commercial Introat Wall St. Cheat Sheet (Wed, Oct 3)

Tuesday, October 2, 2012

• Vivus Boosted by Qsymia and 4 Movers Sparking Chatterat Wall St. Cheat Sheet (Tue, Oct 2)
• Dendreon's Provenge: More Evidence Of A Greater Life Extension Survival Benefitat Seeking Alpha (Tue, Oct 2)
• What Next For Neuralstem?at Seeking Alpha (Tue, Oct 2)
• Can Dendreon Stop The Medivation Invasion?at Seeking Alpha (Tue, Oct 2)

Monday, October 1, 2012

• Will Insurers Determine Dendreon's Success?at Motley Fool (Mon, Oct 1)
• The List: Top 5 Puget Sound commercial property managers (slide show)at bizjournals.com (Mon, Oct 1)
• Insmed Ignites and 4 Healthcare Stocks to Analyze Nowat Wall St. Cheat Sheet (Mon, Oct 1)

Sunday, September 30, 2012

• Dendreon: Will Expansion to Europe Boost Sales?at Wall St. Cheat Sheet (Sun, Sep 30)

Saturday, September 29, 2012

• What's Fueling Savient's Run?at Motley Fool (Sat, Sep 29)

Friday, September 28, 2012

• Healthcare Business Review: Abbott’s Humira Use Expanded, Dendreon Gets Aetna Nodat Wall St. Cheat Sheet (Fri, Sep 28)
• Internal memo details Dendreon's plans for sales forceat bizjournals.com (Fri, Sep 28)
• U.S. Stocks Cap Worst Week Since June Amid Economy Woesat Bloomberg (Fri, Sep 28)
• Dendreon gets boost from Aetna coverage memoAP (Fri, Sep 28)
• Questcor Rises On Dividend, Aetna News Ups Dendreonat Investor's Business Daily (Fri, Sep 28)
• Dendreon Gains After Aetna Expands Coverage of Provengeat Bloomberg (Fri, Sep 28)
• Dendreon Makes Progress, but Issues May Loomat Motley Fool (Fri, Sep 28)
• Dendreon climbs after Aetna says Provenge necessary for more patientsat theflyonthewall.com (Fri, Sep 28)
• FDA Picks Up the Pace, Investors Rejoiceat Motley Fool (Fri, Sep 28)
• Can Stem Cells Regenerate Your Portfolio? Stephen Dunn Says Yesat Seeking Alpha (Fri, Sep 28)
• Biotech Industry Applauds Introduction of the High Technology Small Business Research Incentives ActMarketwired (Fri, Sep 28)

Add DNDN News to My Yahoo!